Pharmacokinetic Drug Interactions MCQs

Welcome to our comprehensive collection of Multiple Choice Questions (MCQs) on Pharmacokinetic Drug Interactions, a fundamental topic in the field of Drug and Pharmaceutical Biotechnology. Whether you're preparing for competitive exams, honing your problem-solving skills, or simply looking to enhance your abilities in this field, our Pharmacokinetic Drug Interactions MCQs are designed to help you grasp the core concepts and excel in solving problems.

In this section, you'll find a wide range of Pharmacokinetic Drug Interactions mcq questions that explore various aspects of Pharmacokinetic Drug Interactions problems. Each MCQ is crafted to challenge your understanding of Pharmacokinetic Drug Interactions principles, enabling you to refine your problem-solving techniques. Whether you're a student aiming to ace Drug and Pharmaceutical Biotechnology tests, a job seeker preparing for interviews, or someone simply interested in sharpening their skills, our Pharmacokinetic Drug Interactions MCQs are your pathway to success in mastering this essential Drug and Pharmaceutical Biotechnology topic.

Note: Each of the following question comes with multiple answer choices. Select the most appropriate option and test your understanding of Pharmacokinetic Drug Interactions. You can click on an option to test your knowledge before viewing the solution for a MCQ. Happy learning!

So, are you ready to put your Pharmacokinetic Drug Interactions knowledge to the test? Let's get started with our carefully curated MCQs!

Pharmacokinetic Drug Interactions MCQs | Page 2 of 4

Q11.
Drugs in patients with renal impairment have same pharmacokinetic profile as in a person without renal failure.
Discuss
Answer: (b).False
Discuss
Answer: (a).Artificial Semipermeable membrane
Q13.
Which of the following will not be a factor governing the removal of substances through dialysis?
Discuss
Answer: (c).Disintegration time
Q14.
Haemodialysis is also known as extracorporeal dialysis.
Discuss
Answer: (a).True
Q15.
The time period for which the plasma concentration of drug remains above minimum effective concentration is known as ______________
Discuss
Answer: (c).Duration of drug of action
Q16.
Which of the following is not a mechanism for pharmacokinetic analysis?
Discuss
Answer: (d).Human model
Q17.
In which of the following models the body is considered to be composed of several compartments?
Discuss
Answer: (a).Compartment model
Q18.
In which of the model peripheral compartments are connected to a central compartment?
Discuss
Answer: (d).Mammillary model
Q19.
Which organs will make up the peripheral compartment?
Discuss
Answer: (d).Pancreas
Q20.
In which model compartments are joined in series?
Discuss
Answer: (b).Caternary model
Page 2 of 4